Quantcast

Latest Neuraminidase inhibitors Stories

0096d0aa4236521eb82f2c43eaa20af81
2010-06-22 10:24:12

Fraudulent product is dangerous to patients allergic to penicillin The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as "Generic Tamiflu" sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. The agency reminds patients who are allergic to or may have experienced adverse reactions...

2010-06-17 14:00:00

Fraudulent product is dangerous to patients allergic to penicillin SILVER SPRING, Md., June 17 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as "Generic Tamiflu" sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. (Logo:...

24f8c69bfb7d626fbae0e242c9df9195
2010-06-01 05:39:57

Scientists from Hong Kong and Canada have identified a chemical compound that can halt the replication of both the H5N1 bird flu virus and the seasonal human flu virus. The scientists discovered that the chemical "nucleozin" fought off both viruses in mice as well as in cell cultures. Identifying new flu drugs is critical as flu viruses mutate and are skillful at evading the limited number of antiviral drugs currently available. "We have now brand-new weapons to combat influenza virus...

2010-05-20 08:00:00

ST. PAUL, Minn., May 20 /PRNewswire/ -- Despite concerns from public health officials, influenza antiviral drugs were not hoarded during the recent H1N1 flu season, according to a new analysis presented recently at the Academy of Managed Care Pharmacy's 22nd Annual Meeting in San Diego by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management. For the study, researchers from Prime and one of its Blue Cross Blue Shield (BCBS) clients compared the use of influenza...

2010-04-28 06:00:00

EMERYVILLE, Calif., April 28 /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco. "This pilot...

2010-04-27 14:30:39

Tamiflu and two other drugs used to treat influenza appear safe for pregnant women and their babies, researchers at UT Southwestern Medical Center have found in a retrospective study of 239 cases of women who received the medications during pregnancy. The study provides "reassuring safety data about commonly used medications," the researchers concluded in their study, which appears in the April issue of Obstetrics and Gynecology. "A woman has to balance the benefits and potential risks of any...

2010-03-31 08:00:00

ST. PAUL, Minn., March 31 /PRNewswire/ -- Prime Therapeutics LLC (Prime), a thought leader in pharmacy benefit management, will present five new studies at the Academy of Managed Care Pharmacy's (AMCP) annual meeting, April 7-10, 2010 in San Diego. Being presented on Friday, April 9 are: Adherence to chronic medication therapy associated with 90-day supplies compared to 30-day supplies. Researchers evaluated whether there is a difference in medication adherence for patients prescribed...

e7b769858459a7075d3689706b1393631
2010-03-28 06:55:00

U.S. doctors reported on Friday that the H1N1 swine flu virus can develop resistance to antivirus treatments very quickly. Government researchers reported cases of two persons with compromised immune systems who developed new strains of the virus after less than two weeks of therapy. The new strains are showing resistance to the antiviral drugs. Bacteria develop resistance to antibiotics quickly, which must be treated carefully. Viruses can do the same and doctors recommended that antiviral...

2010-03-15 05:30:00

EMERYVILLE, Calif., March 15 /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today results from in vivo animal studies and in vitro tests demonstrating that its triple combination antiviral drug (TCAD) therapy is superior relative to double combinations and monotherapy against multiple strains of pandemic and avian influenza viruses. Results of these studies were presented Sunday evening in an oral session at the XII International Symposium on Respiratory...

65f2d6289bd91fef3a9beed3f32af083
2010-03-01 14:55:05

If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it. Researchers at Ohio State University have traced the evolutionary history of the seasonal H1N1 influenza virus, which first infected humans during the 1918 pandemic. It is one of three seasonal influenza A viruses that commonly infect humans. The...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related